Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascletis, Compass Pathways, Elevar, Epsilogen, Gilead Sciences, Hoth, Immuron, Intrommune, Mindbio, Moonlake Immunotherapeutics, Remegen, Stoke, Third Harmonic.